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Abstract: Although a lot of research has been performed, large segmental bone defects caused
by trauma, infection, bone tumors or revision surgeries still represent big challenges for trauma
surgeons. New and innovative bone substitutes are needed. Three-dimensional (3D) printing is a
novel procedure to create 3D porous scaffolds that can be used for bone tissue engineering. In the
present study, solid discs as well as porous cage-like 3D prints made of polylactide (PLA) are coated
or filled with collagen, respectively, and tested for biocompatibility and endotoxin contamination.
Microscopic analyses as well as proliferation assays were performed using various cell types on PLA
discs. Stromal-derived factor (SDF-1) release from cages filled with collagen was analyzed and the
effect on endothelial cells tested. This study confirms the biocompatibility of PLA and demonstrates
an endotoxin contamination clearly below the FDA (Food and Drug Administration) limit. Cells of
various cell types (osteoblasts, osteoblast-like cells, fibroblasts and endothelial cells) grow, spread
and proliferate on PLA-printed discs. PLA cages loaded with SDF-1 collagen display a steady SDF-1
release, support cell growth of endothelial cells and induce neo-vessel formation. These results
demonstrate the potential for PLA scaffolds printed with an inexpensive desktop printer in medical
applications, for example, in bone tissue engineering.
Keywords: 3D-printing; polylactide; collagen; biocompatibility; osteogenesis; angiogenesis
1. Introduction
During the last decade, much knowledge has been acquired in trauma management.
However, large segmental bone defects caused by trauma, infection, bone tumors or revision surgeries
still represent a challenge for trauma surgeons all over the world [1,2]. Until now, the gold standard
for treatment of large bone defects is autologous bone grafting, which, unfortunately, is associated
with severe problems; one or several additional interventions are needed and the transplant material is
limited [3]. Although several materials and various implant options have been developed, the perfect
solution for filling up critical size defects still remains to be found [4].
New and innovative bone substitutes, which should be non-toxic, endotoxin-free, biocompatible
and optimally biodegradable as well as osteoinductive, are needed. One problem concerning bone
substitutes is the fact, that they need high mechanical stability and should simultaneously express a
porous structure for ingrowth of bone, tissue and cells. Moreover, bone substitutes should stimulate
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osseointegration. This could be achieved by modifications of the material with active compounds
displaying the requested features. One possible solution are materials consisting of a mechanical stable
structure (e.g., hydroxyapatite) [5] filled, coated or modified with polymers representing soft part,
e.g., hydrogels [6], which can be altered with cells or bioactive molecules [7]. Many studies in the
last years demonstrated that the critical point for bone tissue engineering is not the induction of bone
growth but the supply of the implant with nutrients and oxygen, showing that vascularization of the
implant and its surroundings is the main requirement [8,9]. Therefore, new bone substitutes should
also elicit angiogenic effects. One option to create the requested effects together with osteogenesis
is the immobilization of bioactive molecules, for example incorporation of SDF-1 (stromal-derived
factor), which is known to act chemotactically on endothelial (progenitor) cells and thereby to induce
angiogenesis [10,11].
Three-dimensional (3D) printing is a simple procedure to create 3D porous scaffolds used for bone
tissue engineering [12]. A promising material is polylactide, a polymer which is known to be degraded
by hydrolysis to harmless and non-toxic monomers [13]. Moreover, it displays mechanical stability,
which is why it has been studied and employed in various medical studies and applications [14,15].
One soft material being used together with mechanically stable materials is collagen. Collagens are
extracellular matrix (ECM) molecules and are widely employed as biomaterials due to their excellent
behaviour [16], even in bone tissue engineering [17]. It is inexpensive, well-tolerated and easy to
handle and modify. Moreover it is degraded in the body by collagenases, releasing non-toxic and
non-immunogenic peptides [18]. Collagens from various sources exist [19], but rat tail or bovine
sources are the most commonly used. Collagen has been used for tissue engineering [20,21] and
delivery of various bioactive molecules [22] for decades, emphasizing its potential as a biomaterial
for various medical applications. Besides bone tissue engineering studies, collagen-based (hydro)gels
or scaffolds, have been suggested, inter alia, for use in cartilage repair [23], wound-infection [24],
tendon tissue engineering [25], neurodegenerative diseases [26] and nucleus pulposus regeneration [27].
Moreover, Bersini et al. combined computational tools with an experimental approach including
hydrogels consisting of fibrin and collagen to engineer vascularized bone-mimicking tissues [28].
In the present study, solid discs as well as porous cage-like 3D structures made of PLA were coated
and filled with collagen. These materials were employed for biocompatibility evaluation and testing of
endotoxin contamination. The effects on various cell types were tested in vitro and interpreted with
regard to their potential usefulness in medical applications.
2. Results and Discussion
2.1. Scaffold Characterization
PLA scaffolds were fabricated using a 3D-printer, Ultimaker 2+, with a 0.25 mm nozzle.
Images taken by scanning electron microscopy shown in Figure 1 demonstrate the rough and inherent
surface of the printed 3D models due to the limited resolution of the 3D-printer. The three-dimensional
reconstruction of the cage-like model as well as the inside views taken by a microcomputed tomography
technique demonstrate a scaffold structure with pores large enough for cells to invade from the top as
well as from side walls. The comparison of the designed 3D model and the printed results demonstrates
some structural imperfections due to the limiting factors of the 3D print technology. Threads and
loose particles as well as geometric deviations caused by the fabrication process are estimated as
non-relevant and consciously accepted. The hole in the center of the scaffold was designed to facilitate
gel injection into the scaffold.
Polylactide is a promising starting material for scaffolds used for biomedical application.
However, not many studies utilized low-cost and “easy-to-handle” desktop printers, which can
be afforded and handled by everyone [29,30]. The structure of the printed scaffolds hints to positive
properties for cell growth as well as modification options; both facts being prerequisites for a material
usable in bone tissue engineering.
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Figure 1. (A) Scanning electron microscope (SEM) image gallery of the PLA scaffolds. Single Images 
(100×) are stacked together manually; (B) µCT 3D volume rendering of polylactide (PLA) cage and 
µCT-slices as multiplanar reconstruction (MPR) images from the top and bottom site of the PLA cage. 
2.2. Endotoxin Contamination 
Endotoxins are lipopolysaccharides (LPS), located on the outer cell membrane of Gram-negative 
bacteria. Ubiquitously present, they can enter the blood stream of humans and induce immunological 
responses resulting in inflammation and infection, possibly leading to multiple organ failure and 
eventually to death [31,32]. Once contaminated, removal of endotoxins from infected materials is 
almost impossible as they are resistant to high temperature and even acidic solutions. Only extreme 
high temperatures or extreme acidic solutions can destroy endotoxins—conditions that would 
destroy most biomaterials. Therefore, avoiding endotoxin contamination during syntheses processes 
is highly recommended [33]. To our knowledge, no studies have been performed to determine 
endotoxin contamination in PLA scaffolds after 3D printing.  
In order to ensure, that polylactide scaffolds do not contain endotoxins after printing, we 
performed limulus amebocyte lysate-assays (LAL-assays) to determine endotoxin contamination 
before and after printing in the supernatant of PLA incubated in PBS (phosphate buffered saline, 
Figure 2). PLA was used directly after taking it out of the package (red circle 5) as well as after being 
in the air for a few days (red circle 6) and analyzed for endotoxin contamination; LAL-assay 
demonstrates an endotoxin contamination well above the FDA-limit (0.5 EU/mL). In contrast,  
LAL-assay demonstrated an endotoxin contamination of our PLA printed scaffolds from  
0.1–0.25 EU/mL (Figure 2, green circles), which is clearly below the FDA-limit (0.5 EU/mL). 
Most likely the high temperatures (up to 240 °C) during printing processes are sufficiently high 
to destroy any present endotoxins. Similar findings were reported by Neches et al. who describe the 
intrinsic sterility of 3D printing due to, among other factors, the high fusion modeling temperatures [34]. 
After printing, the PLA disks or -scaffolds are transferred directly to ethanol-containing solutions 
and handled under sterile conditions to minimize further endotoxin contaminations.  
2.3. Biocompatibility 
In order to ensure biocompatibility of our PLA scaffolds, printed cages were incubated in 
medium for 12, 24 and 48 h. The supernatants were used for incubation of L929 cells seeded in  
96 wells for 24 h and viability was tested with a MTT assay. This protocol is in accordance to  
ISO-10993-5: Biological evaluation of medical devices. Figure 3 demonstrates the viability of cells for 
all three time points. Cell viability of 100% corresponds to cells growing on tissue-culture-treated 
polystyrene substrates (medium control). According to ISO 10993-5, cell viabilities > 70% indicate no 
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Figure 1. (A) Scanning electron microscope (SEM) image gallery of the PLA scaffolds. Single Images
(100×) are stacked together manually; (B) µCT 3D volume rendering of polylactide (PLA) cage and
µCT-slices as multiplanar reconstruction (MPR) images from the top and bottom site of the PLA cage.
2.2. Endotoxin Contamination
Endotoxins are lipopolysaccharides (LPS), located on the outer cell membrane of Gram-negative
bacteria. Ubiquitously present, they can enter the blood stream of humans and induce immunological
responses resulting in inflammation and infection, possibly leading to multiple organ failure and
eventually to death [31,32]. Once contaminated, removal of endotoxins from infected materials is
almost impossible as they are resistant to high temperature and even acidic solutions. Only extreme
high temperatures or extreme acidic solutions can destroy endotoxins—conditions that would destroy
most biomaterials. Therefore, avoiding endotoxin contamination during syntheses processes is highly
recommended [33]. To our knowledge, no studies have been performed to determine endotoxin
contamination in PLA scaffolds after 3D printing.
In order to ensure, that polylactide scaffolds do not contain endotoxins after printing,
we performed limulus amebocyte lysate-assays (LAL-assays) to determine endotoxin contamination
before and after printing in the supernatant of PLA incubated in PBS (phosphate buffered saline,
Figure 2). PLA was used directly after taking it out of the package (red circle 5) as well as
after being in the air for a few days (red circle 6) and analyzed for endotoxin contamination;
LAL-assay demonstrates an endotoxin contamination well above the FDA-limit (0.5 EU/mL).
In contrast, LAL-assay demonstrated an endotoxin contamination of our PLA printed scaffolds from
0.1–0.25 EU/mL (Figure 2, green circles), which is clearly below the FDA-limit (0.5 EU/mL).
Most likely the high temperatures (up to 240 ◦C) during printing processes are sufficiently high
to destroy any present endotoxins. Similar findings were reported by Neches et al. who describe the
intrinsic sterility of 3D printing due to, among other factors, the high fusion modeling temperatures [34].
After printing, the PLA disks or -scaffolds are transferred directly to ethanol-containing solutions and
handled under sterile conditions to minimize further endotoxin contaminations.
2.3. Biocompatibility
In order to ensure biocompatibility of our PLA scaffolds, printed cages were incubated in medium
for 12, 24 and 48 h. The supernatants were used for incubation of L929 cells seeded in 96 wells
for 24 h and viability was tested with a MTT assay. This protocol is in accordance to ISO-10993-5:
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Biological evaluation of medical devices. Figure 3 demonstrates the viability of cells for all three
time points. Cell viability of 100% corresponds to cells growing on tissue-culture-treated polystyrene
substrates (medium control). According to ISO 10993-5, cell viabilities > 70% indicate no cytotoxic
effects, whereas cell viability between 0% and 40% represents high cytotoxicity as seen in the positive
controls A and B (ZDEC and ZDBC: polyurethane matrices stabilized with organic zinc) with values
below 25% viability.
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Figure 2. Determination of endotoxin concentration in PLA disks. Endotoxin concentration was
determined in supernatants of PLA strings before printing directly after unpacking (red circle 5) and
after a few days at the air (red circle 6) and in PLA disks after printing incubated for 24 h (1 + 2) or
48 h (3 + 4): green circles. The trendline corresponds to standards with 0.1, 0.25, 0.5 and 1.0 EU/mL
(black quarders). The diagram shows that endotoxin concentrations are well below the FDA limit of
0.5 EU/mL.
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Figure 3. Confirmation of biocompatibility of PLA disks. MTT-tests were performed analogue to
ISO 10993-5 and confirmed the biocompatibility of PLA disks as demonstrated by viability of cells
after incubation for 12, 24 and 48 h in PLA medium, respectively, compared to standard cell medium.
Medium control: standard cultivation medium; positive controls: ZDEC and ZDBC: polyurethane
matrices stabilized with organic zinc.
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2.4. Microscopic Analyses
Different cell types stably expressing eGFP (human primary osteoblasts: hOB, osteosarcoma
cells: SaOS-2) or mCherry (human umbilical vein endothelial cells: HUVEC, normal human dermal
fibroblasts: NHDF) were seeded on collagen-coated PLA discs to analyze cell growth. Figure 4 shows
an equal distribution of all tested cells seeded on PLA discs.
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Figure 4. Microscopic analysis of different cell types seeded on PLA discs. (A) hOB (human primary
osteoblasts; (B) normal human dermal fibroblasts: NHDF; (C) human umbilical vein endothelial cells:
HUVEC; and (D) osteosarcoma cells: SaOS-2. Scale bars represent 400 µm.
2.5. Proliferation
For proliferation tests, we seeded cells on PLA scaffolds coated with or without collagen solutions.
The results demonstrated statistically significant better proliferation of various cell types on PLA
discs coated with rat tail or bovine collagen (Figure 5B,C), compared to non-coated discs (Figure 5A,
p≤ 0.05). The shape of these growth curves is similar, and, except for hOB cells the overall proliferation
of the cells is slightly better on discs coated with bovine collagen, however, these differences are not
statistically significant (p > 0.05).
It has been demonstrated that PLA is a biocompatible and biodegradable material [13,35,36].
However, only few in vitro studies have been performed concerning 3D-printed scaffolds employing
PLA. One study was performed with murine MC3T3 cells, confirming the biocompatibility of
PLA scaffolds. This study used different coatings (hyaluron and pullulan) and found different
effects of the coatings on cells [30]. Rosenzweig et al. tested chondrocytes and nucleus pulposus
cells on PLA scaffolds and demonstrated their increase in proliferation [37]. Yang et al. combined
polylactide-co-glycolide (PGLA) with hydroxyapatite and found an osteoinductive effect with human
bone marrow derived stem cells (hBMSCs) [38]. A similar study was performed by Senatov [39].
Wurm et al. manufactured PLA samples by fused deposition modeling and tested their biocompatibility
with human fetal osteoblasts (hFOB) [40]. They demonstrated that their PLA samples showed no
cytotoxicity, however, hFOB demonstrated reduced cell growth compared to polystyrene control,
probably due to differences in surface roughness. These effects might be masked in our approach
by collagen coating. Rodina tested migration and proliferation of murine mesenchymal stem cells
on electrospun PLA scaffolds coated with collagen [41,42]—completely different to our scaffolds,
but their study demonstrates possible combination of PLA and collagen. Concerning biocompatibility
of PLA, our study is in accordance with the described literature, however, it is the first study
analyzing 3D-printed PLA discs coated with collagen with different human cells in vitro. We could
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demonstrate that the cells adhere to collagen-coated PLA discs and exhibit their typical morphology.
Moreover, all cell types proliferate on the discs over a period of ten days. This is especially interesting
with regards to endothelial cells as these cells represent an angiogenic cell type and many studies
showed that angiogenesis is the critical point of tissue regeneration in almost every tissue. Until now,
only few groups demonstrated a positive effect on angiogenic factors of human stem cells in
combination with polylactide [43–45].
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Figure 5. Proliferation assays on PLA discs with different cell types. (A) without collagen; (B) PLA discs
coated with rat tail collagen; (C) PLA discs coated with bovine collagen. Blue: HUVEC, red: NHDF,
green: hOB and lilac: SaOS-2.
2.6. SDF-1 Immobilization and Release
In order o construct a mat rial which can be applied as bone substitute, a cage-like structure was
printed with pores large enough for cells, vessels and/or bone to grow inside. To construct a material
that enhances angiogenesis in the first place, we immobilized SDF-1 in the PLA collagen cage and
measured the release kinetics of this factor from the cage.
For release kinetics, 500 ng SDF-1 were immobilized in collagen gel in PLA cages and its release
was measured over 48 h. Interestingly, we could not observe a high initial burst release, but a relative
steady release. After 48 h, 50% of the initially immobilized SDF-1 is still in the cage (Figure 6).
In former studies, we could emonstrated th t SDF-1 bound t collagen or hydrogels keeps
its functional bioactivity, induces angiogenetic effects nd, as a consequence, supports bone tissue
regeneration [46–48]. In these studies, we observed a high initial rel ase of immobilized SDF-1,
which was sufficient to induce angiogenetic effects; however, a steady release over a longer time period
as observed in the present study with the PLA collagen cages seems to be preferable [11,49,50].
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for cervical diseases [54] and Kao et al. coated PLA with poly(dopamine) for bone tissue engineering. 
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Figure 6. SDF-1 release from PLA collagen cages. SDF-1 is released from collagen inside the 3D-printed
cages in a steady manner and after 48 h approximately 50% are still inside the cage.
2.7. Angiogenic Potential
mCherry-expressing HUVECs were seeded on PLA cages loaded with SDF-1 immobilized in
bovine collagen (Figure 7). The cells adhere to the cage and start to grow inside it. Thereby they start
to form neo-vessel-like structures comparable to cells grown in Matrigel [51].
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Figure 7. HUVECs seeded on PLA collagen–SDF-1 scaffolds. The cells adhere to the cage and seem to
grow from the outside of the cage into the collagen gel (A). Thereby they start to form neo-vessel-like
structures comparable to cells grown in Matrigel (B). Scale bar represents 2000 µm.
These results are promising concerning the application of mechanically stable PLA collagen–SDF-1
constructs as bone substitutes. The produced scaffolds are biocompatible, demonstrate a steady
release of t im obilized facto s and induce neo-ve sel formation in endoth lial cells. Until now,
no such approach has been tested. Pinese et al. combined PLA p lymers as knitted patches
with collagen/chondroitin ulfate for ligament regen ration [52]. Heo et al. combi ed PLA with
gelatin hydrogels and showe that human adipose-derived stem cells can b drifted to osteogenic
differentiatio d suggest this material for bone tissue engineering [53]. Yin used 3D-printed cages
for cervical diseases [54] and Kao et al. coated PLA with poly(dopamine) for bone tissue engineering.
They demonstrated a higher expression of ALP and osteocalcin in adipose-derived stem cells after
seeding on these constructs. Moreover, they could show that some proteins associated with angiogenic
differentiation were upregulated [43]. Concerning angiogenesis, Sekula et al. reported a positive
effect of PLA on human umbilical cord-derived mesenchymal stem cells on gene expression of
endothelial markers; however they did not analyze vessel formation in an angiogenesis assay [45].
Using an approach comparable to Kao [43], Yeh et al. demonstrated an upregulation of osteogenic and
angiogenic markers of bone marrow stem cells on 3D-printed PLA scaffolds after immobilization of
poly-dopamine [44]. To our knowledge, the present work is the only study testing angiogenic associated
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aspects with PLA scaffolds printed on a simple desktop 3D-printer coated or filled with collagen I
employing inter alia endothelial cells and performing proliferation as well as angiogenesis assays.
Concerning in vivo evaluation of PLA constructs, Chou et al. used a PLA cage as a carrier for
bone chips that induced bone regeneration in a rabbit model [13]. They demonstrated that morselized
corticocancellous bone chips were converted into a structured cortical bone graft and that the PLA cage
was already completely degraded 12 weeks after implantation. This demonstrates that the transfer of
our in vitro results to in vivo studies is generally possible.
Our approach displays an inexpensive, easily constructed scaffold with the necessary mechanical
stability and a soft material inside that can be modified with various cytokines or even cells to induce
angiogenesis, and as a consequence bone regeneration. Proof of concept in a rat in vivo model is part
of the follow-up-study. Before analyzing the potential of our scaffold to enhance bone regeneration in
an in vivo femur defect model in the rat, further tests to characterize the mechanical stability of our
3D-prints loaded with collagen I will be performed. Mechanical tests as well as in vivo experiments
will clarify the potential of our approach for bone tissue engineering.
3. Materials and Methods
3.1. 3D-Printing
For 3D-printing we used commercially available PLA filament (Ultimaker silver metallic PLA,
iGo3D, Hannover, Germany) with a diameter of 2.85 ± 0.10 mm. Mechanical, thermal and other
properties are listed in the technical data sheet from Ultimaker. Sanchez et al. give a good overview
about material characterization methods for PLA filaments in 3D printing [55]. All PLA discs and
cages were designed with a 3D modeling software (Autodesk® Inventor Professional 2013, Autodesk,
San Rafael, CA, USA) so that they fit to the 24 well of an ultra-low attachment plate (Corning,
Wiesbaden, Germany). The 3D model file generated by the Autodesk Inventor software was exported
to a convenient file format (STL).
For the 3D print pre-processing this file was imported into the CURA 2.5 software (Ultimaker B.V.,
Geldermasen, The Netherlands), previewed, scaled and adjusted as necessary. Cura slices the model
ready for print with the 3D-printer Ultimaker 2+ (Ultimaker B.V., Geldermasen, The Netherlands)
employing the smallest available nozzle size (0.25 mm). A slightly modified high quality profile in
Cura 2.5 with a layer height of 0.06 mm, 100% infill, 200 ◦C nozzle temperature and 60 ◦C build plate
temperature has shown the best results.
Figure 8 demonstrates the difference between the designed 3D model and the 3D printed objects.
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3.2. Quality Control
For quality control purposes, all the printed objects underwent detailed examination by means of
stereo light microcopy (Leica MZ 16A) as mentioned above, scanning electron microscopy (FEI Quanta
200FEG) and micro computational tomography (Scanco µCT40). SEM investigation was done under
low vacuum condition to avoid disturbing artefacts due to the electrical isolating characteristic of the
PLA material. The SEM investigation under low vacuum condition is recommended especially for
non-conductive samples with undergoing cavities were the available sputter coating techniques fails
to cover the whole sample surfaces.
Parts of the PLA cage surfaces are shown in Figure 9 to demonstrate the limits of precision of the
applied 3D printing technique. To make sure that a high degree of connectivity was achieved for the
printed material the PLA cages were scanned with a micro-CT system. Micro-CT reconstructions as
shown in Figure 10 demonstrate the internal designed structures with a sufficient porosity.
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3.3. Biocompatibility
In vitro cytotoxicity was analyzed employing the MTT ([3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazoliumbromid)]) assay analogous to ISO 10993-5. Mouse L929 cells (20.000 cells/well)
were seeded in a 96-well tissue culture polystyrene (TCPS) plate for 24 h. Directly after printing
PLA constructs were incubated in 500 µL cell media for 24 h. 100 µL of this extract were given
to L929 cells in the 96 well plate. After an incubation time of 24 h the MTT assay was performed
according to ISO 10993-5. The colorimetric readout was performed at a wavelength of 570 nm (reference
wavelength 650 nm). Polyurethane membranes stabilized with organic zinc derivatives ZDEC (zinc
diethyl dithiocarbamate) and ZDBC (zinc dibutyl dithiocarbamate) (Food and Drug Safety Center,
Hatano Research Institute, Hadano, Japan), were used as positive controls. These controls induce a
reproducible cytotoxic reaction.
3.4. Endotoxin Contamination
Prior to the cell experiments, the 3D-printed PLA constructs were tested for endotoxin
contamination employing the endpoint chromogenic LAL (limulus amebocyte lysate) assay (Lonza,
Basel, Switzerland). The assay was performed according to the manufacturer’s recommendations.
For preparation of the endotoxin analyte solution, PLA discs and cages were incubated in 1 mL water
directly after printing without preceding washing-steps for 24 h at 37 ◦C (conditions were transferred
from ISO 10993-5: 2009; Biological evaluation of medical devices) in order to extract any potential
endotoxin from the PLA matrix. the supernatant (50 µL) was employed in the LAL test. Parallel to
sampling of the analyte solutions, a standard curve was established and the analysis results compared
to positive controls (provided by the manufacturer (Lonza, Basel, Switzerland) within the LAL kit)
and negative control (pure endotoxin free water).
3.5. Coating/Filling of Discs/Cages with Collagen I
Solid PLA discs were coated with bovine (Viscofan, Weinheim, Germany) or rat tail collagen
(Invitrogen, Karlsruhe, Germany). Collagens were diluted 1:100 with PBS and discs were incubated
for one hour to assure even coating.
3D cages were filled with a collagen gel solution following an established protocol [56,57].
Briefly, collagen type I (3 mg/mL bovine, Viscofan, Weinheim, Germany), aqua dest, M199 (10×),
NaHCO3 and NaOH and SDF-1 (500 ng, Miltenyi, Bergisch Gladbach, Germany) were combined within
an ice bath to prevent polymerization of the solution. Next, 300 µL of the liquid collagen solution
was pipetted into a PLA cage sitting in a 24-well ultra-low attachment plate (Corning, Wiesbaden,
Germany) and allowed to polymerize.
3.6. Cells
Four cell types were used to analyze cell growth and viability on 3D-printed PLA discs coated with
bovine or rat tail collagen. Normal human dermal fibroblasts (NHDF, Promega, Karlsruhe, Germany),
human primary osteoblasts (hOB [48,58]), osteoblast-like cells (SaOS, ATCC, Manassas, VA, USA) and
endothelial cells (HUVEC, Promega, Karlsruhe, Germany) were seeded onto discs, into or onto cages,
respectively, sitting in a 24-well ultra-low attachment plate. Cells (100,000) were seeded in all cases.
3.7. Viability
Proliferation was measured over a 10-day period with alamarBlue-assay (Invitrogen,
Karlsruhe, Germany) according to the manufacturer’s protocol.
To allow analysis by fluorescent microscopy cells were transduced with lentiviral vectors
encoding mCherry or enhanced green fluorescent protein. Vector supernatants were collected and
concentrated from transfected 293T producer cells as previously described [59]. For gene transfer,
15.000 human osteoblasts (hOB) or HUVEC were seeded into 24-well tissue culture plates (Greiner,
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Frickenhausen, Germany) in 500 µL media supplemented with 5 µg/mL protamine sulfate. Two rounds
of transduction on day 1 and 3 were performed at a cumulative multiplicity of infection (MOI) of
~100 to achieve >98% gene marking. Transduction efficiency was confirmed by fluorescence microscopy
(Wilovert AFL30, Hundt, Wetzlar, Germany) and flow cytometry FACSCalibur (BD Biosciences,
San Jose, CA, USA) using the CellQuestPro Software (BD Biosciences, San Jose, CA, USA). The different
cell types were seeded as monocultures on PLA discs or on the cages and the spreading, morphology
and distribution of the cells analyzed microscopically with a fluorescent microscope.
3.8. SDF-1 Release Assay
Three-dimensional cages were filled with bovine or rat tail collagen immobilized with
fluorescein-linked SDF-1. Release kinetics of SDF-1-FITC from the PLA collagen–cages were measured via
fluorescence reading in the supernatant (Glomax-Multidetection System, Promega, Karlsruhe, Germany).
3.9. Statistical Analysis
Statistical analysis was performed using SPSS 22.0 software (SPSS Inc., Chicago, IL, USA).
Results are presented as means ± standard deviation. At least triplicate measurements for each
time point and experimental condition were performed. Differences corresponding to p < 0.05 were
considered statistically significant.
4. Conclusions
Polylactide is an interesting material for 3D-printing in biomaterial research. This study confirms
its biocompatibility and demonstrates an endotoxin contamination clearly below the FDA limit.
Cells of various cell types (osteoblasts, fibroblasts and endothelial cells) grow, spread and proliferate
on PLA-printed discs. PLA cages loaded with SDF-1–collagen support cell growth of endothelial cells
and induce neo-vessel formation. These results demonstrate the potential for PLA scaffolds in medical
applications, for example, in bone tissue engineering. Tests of mechanical stability as well as in vivo
tests employing a femur defect model in the rat will define the potential to induce angiogenesis and
bone regeneration of the described scaffolds.
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